NCT01823913View on ClinicalTrials.gov

Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions
Healthy
Interventions
DRUG

Test formulation

A single oral dose of a combination tablet of amlodipine orotate 10mg and valsartan 160mg

DRUG

Reference formulation

A single oral dose of a combination tablet of amlodipine besylate 10mg and valsartan 160mg

Trial Locations (1)

120-752

Severance Hospital, Seoul

All Listed Sponsors
lead

Severance Hospital

OTHER

NCT01823913 - Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter